Yep the normal R/E standards should apply here. With that in mind a conservative valuation would be a 2.75 revenue multiple....an upper level would be around 3.50 - 4.00.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025